The data showed a trend towards patients being randomised to FMT having a larger increase in HrQoL at week 8 compared with patients randomised to fidaxomicin and vancomycin.
← all excerpts
Health-related quality of life in patients with recurrent <i>Clostridioides difficile</i> infections.
1
—
—